Statistics for Retention among transgender women treated with dolutegravir associated with tenofovir/ lamivudine or emtricitabine in Argentina: TransViiV study
Total visits
| views | |
|---|---|
| Retention among transgender women treated with dolutegravir associated with tenofovir/ lamivudine or emtricitabine in Argentina: TransViiV study | 6 |
Total visits per month
| views | |
|---|---|
| julio 2024 | 0 |
| agosto 2024 | 1 |
| septiembre 2024 | 0 |
| octubre 2024 | 0 |
| noviembre 2024 | 0 |
| diciembre 2024 | 0 |
| enero 2025 | 0 |
File Visits
| views | |
|---|---|
| 12_2023_Frola_Retention in care among transgender women treated with Dolutegravir associated with TenofovirLamivudine or Emtricitabine in Argentina TransViiV study.pdf | 8 |